{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:36:12Z","timestamp":1757619372728,"version":"3.44.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82201484"],"award-info":[{"award-number":["82201484"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2024JJ4083"],"award-info":[{"award-number":["2024JJ4083"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03942-8","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T14:20:50Z","timestamp":1753194050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiple endocrine neoplasia type 1 with neuroglycopenic symptoms with a novel heterozygous MEN1 gene mutation"],"prefix":"10.1186","volume":"23","author":[{"given":"Xinchen","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixiong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lite","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"3942_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","volume":"17","author":"A Al-Salameh","year":"2021","unstructured":"Al-Salameh A, Cadiot G, Calender A, Goudet P, Chanson P. Clinical aspects of multiple endocrine neoplasia type 1. Nat Rev Endocrinol. 2021;17:207\u201324.","journal-title":"Nat Rev Endocrinol"},{"key":"3942_CR2","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.1210\/jc.2013-1768","volume":"99","author":"TD Goncalves","year":"2014","unstructured":"Goncalves TD, Toledo RA, Sekiya T, Matuguma SE, Maluf Filho F, Rocha MS, et al. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life. J Clin Endocrinol Metab. 2014;99:E89-96.","journal-title":"J Clin Endocrinol Metab"},{"key":"3942_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","volume":"42","author":"ML Brandi","year":"2021","unstructured":"Brandi ML, Agarwal SK, Perrier ND, Lines KE, Valk GD, Thakker RV. Multiple Endocrine Neoplasia Type 1: Latest Insights. Endocr Rev. 2021;42:133\u201370.","journal-title":"Endocr Rev"},{"key":"3942_CR4","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97:2990\u20133011.","journal-title":"J Clin Endocrinol Metab"},{"key":"3942_CR5","doi-asserted-by":"crossref","unstructured":"van den Broek MFM, van Nesselrooij BPM, Pieterman CRC, Verrijn Stuart AA, van de Ven AC, de Herder WW, et al. Clues For Genetic Anticipation In Multiple Endocrine Neoplasia Type 1. J Clin Endocrinol Metab. 2020;105(7)","DOI":"10.1210\/clinem\/dgaa257"},{"key":"3942_CR6","doi-asserted-by":"crossref","unstructured":"Ruggeri RM, Benevento E, De Cicco F, Fazzalari B, Guadagno E, Hasballa I, et al. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies. J Endocrinol Invest. 2022.","DOI":"10.1007\/s40618-022-01905-4"},{"key":"3942_CR7","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1158\/1078-0432.CCR-19-2884","volume":"26","author":"AT Scott","year":"2020","unstructured":"Scott AT, Weitz M, Breheny PJ, Ear PH, Darbro B, Brown BJ, et al. Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors. Clin Cancer Res. 2020;26:2011\u201321.","journal-title":"Clin Cancer Res"},{"key":"3942_CR8","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1055\/s-0044-1786397","volume":"50","author":"KR Kumar","year":"2024","unstructured":"Kumar KR, Cowley MJ, Davis RL. Next-Generation Sequencing and Emerging Technologies. Semin Thromb Hemost. 2024;50:1026\u201338.","journal-title":"Semin Thromb Hemost"},{"key":"3942_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"3942_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.775244","volume":"13","author":"L Lin","year":"2021","unstructured":"Lin L, Wu Y, Chen Z, Huang L, Wang L, Liu L. Severe Hypoglycemia Contributing to Cognitive Dysfunction in Diabetic Mice Is Associated With Pericyte and Blood-Brain Barrier Dysfunction. Front Aging Neurosci. 2021;13: 775244.","journal-title":"Front Aging Neurosci"},{"key":"3942_CR11","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/bjs.11632","volume":"107","author":"DJ van Beek","year":"2020","unstructured":"van Beek DJ, Nell S, Verkooijen HM, Borel Rinkes IHM, Valk GD, Vriens MR. Surgery for multiple endocrine neoplasia type 1-related insulinoma: long-term outcomes in a large international cohort. Br J Surg. 2020;107:1489\u201399.","journal-title":"Br J Surg"},{"key":"3942_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1053\/j.seminoncol.2012.11.001","volume":"40","author":"DS Klimstra","year":"2013","unstructured":"Klimstra DS. Pathology reporting of neuroendocrine tumors: essential elements for accurate diagnosis, classification, and staging. Semin Oncol. 2013;40:23\u201336.","journal-title":"Semin Oncol"},{"key":"3942_CR13","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S2213-8587(15)00043-1","volume":"3","author":"CJ Yates","year":"2015","unstructured":"Yates CJ, Newey PJ, Thakker RV. Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1. Lancet Diabetes Endocrinol. 2015;3:895\u2013905.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3942_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","volume":"14","author":"JM de Laat","year":"2016","unstructured":"de Laat JM, van der Luijt RB, Pieterman CR, Oostveen MP, Hermus AR, Dekkers OM, et al. MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients. BMC Med. 2016;14:182.","journal-title":"BMC Med"},{"key":"3942_CR15","doi-asserted-by":"publisher","first-page":"R145","DOI":"10.1530\/ERC-19-0372","volume":"27","author":"SM Sadowski","year":"2020","unstructured":"Sadowski SM, Pieterman CRC, Perrier ND, Triponez F, Valk GD. Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature. Endocr Relat Cancer. 2020;27:R145\u201361.","journal-title":"Endocr Relat Cancer"},{"key":"3942_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1677\/ERC-07-0221","volume":"15","author":"TR Halfdanarson","year":"2008","unstructured":"Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer. 2008;15:409\u201327.","journal-title":"Endocr Relat Cancer"},{"key":"3942_CR17","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1001\/jamainternmed.2019.1747","volume":"179","author":"EA Alore","year":"2019","unstructured":"Alore EA, Suliburk JW, Ramsey DJ, Massarweh NN, Balentine CJ, Singh H, et al. Diagnosis and Management of Primary Hyperparathyroidism Across the Veterans Affairs Health Care System. JAMA Intern Med. 2019;179:1220\u20137.","journal-title":"JAMA Intern Med"},{"key":"3942_CR18","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1073\/pnas.1920017117","volume":"117","author":"AR Wasylishen","year":"2020","unstructured":"Wasylishen AR, Sun C, Chau GP, Qi Y, Su X, Kim MP, et al. Men1 maintains exocrine pancreas homeostasis in response to inflammation and oncogenic stress. Proc Natl Acad Sci U S A. 2020;117:6622\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3942_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1530\/ERC-21-0247","volume":"29","author":"O Lakiza","year":"2022","unstructured":"Lakiza O, Lutze J, Vogle A, Williams J, Abukdheir A, Miller P, et al. Loss of MEN1 function impairs DNA repair capability of pancreatic neuroendocrine tumors. Endocr Relat Cancer. 2022;29:225\u201339.","journal-title":"Endocr Relat Cancer"},{"key":"3942_CR20","doi-asserted-by":"crossref","unstructured":"Marini F, Giusti F, Tonelli F, Brandi ML. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1. Int J Mol Sci. 2021;22(8).","DOI":"10.3390\/ijms22084041"},{"key":"3942_CR21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/14737140.2019.1693893","volume":"19","author":"L Lee","year":"2019","unstructured":"Lee L, Ito T, Jensen RT. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies. Expert Rev Anticancer Ther. 2019;19:1029\u201350.","journal-title":"Expert Rev Anticancer Ther"},{"key":"3942_CR22","doi-asserted-by":"crossref","unstructured":"H\u00f6lzen L, Schultes B, Meyh\u00f6fer SM, Meyh\u00f6fer S. Hypoglycemia Unawareness-A Review on Pathophysiology and Clinical Implications. Biomedicines. 2024;12(2).","DOI":"10.3390\/biomedicines12020391"},{"key":"3942_CR23","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1210\/clinem\/dgaa539","volume":"105","author":"E Lontchi-Yimagou","year":"2020","unstructured":"Lontchi-Yimagou E, Aleksic S, Hulkower R, Gospin R, Goyal A, Kuo B, et al. Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure. J Clin Endocrinol Metab. 2020;105:3416\u201327.","journal-title":"J Clin Endocrinol Metab"},{"key":"3942_CR24","doi-asserted-by":"crossref","unstructured":"Broz J, Campbell MD, Urbanova J, Nunes MA, Brunerova L, Rahelic D, et al. Characterization of Individualized Glycemic Excursions during a Standardized Bout of Hypoglycemia-Inducing Exercise and Subsequent Hypoglycemia Treatment-A Pilot Study. Nutrients. 2021;13(11).","DOI":"10.3390\/nu13114165"},{"key":"3942_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/cns.13186","volume":"26","author":"N Dewan","year":"2020","unstructured":"Dewan N, Shukla V, Rehni AK, Koronowski KB, Klingbeil KD, Stradecki-Cohan H, et al. Exposure to recurrent hypoglycemia alters hippocampal metabolism in treated streptozotocin-induced diabetic rats. CNS Neurosci Ther. 2020;26:126\u201335.","journal-title":"CNS Neurosci Ther"},{"key":"3942_CR26","doi-asserted-by":"crossref","unstructured":"Christou MA, Christou PA, Kyriakopoulos C, Christou GA, Tigas S. Effects of Hypoglycemia on Cardiovascular Function in Patients with Diabetes. Int J Mol Sci. 2023;24(11).","DOI":"10.3390\/ijms24119357"},{"key":"3942_CR27","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/dme.14240","volume":"37","author":"BE de Galan","year":"2020","unstructured":"de Galan BE, McCrimmon RJ, Ibberson M, Heller SR, Choudhary P, Pouwer F, et al. Reducing the burden of hypoglycaemia in people with diabetes through increased understanding: design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo-RESOLVE) project. Diabet Med. 2020;37:1066\u201373.","journal-title":"Diabet Med"},{"key":"3942_CR28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2337\/dc16-2177","volume":"40","author":"P Novodvorsky","year":"2017","unstructured":"Novodvorsky P, Bernjak A, Chow E, Iqbal A, Sellors L, Williams S, et al. Diurnal Differences in Risk of Cardiac Arrhythmias During Spontaneous Hypoglycemia in Young People With Type 1 Diabetes. Diabetes Care. 2017;40:655\u201362.","journal-title":"Diabetes Care"},{"key":"3942_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S2213-8587(18)30315-2","volume":"7","author":"International Hypoglycaemia Study G","year":"2019","unstructured":"International Hypoglycaemia Study G. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2019;7:385\u201396.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3942_CR30","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00125-020-05366-3","volume":"64","author":"SA Amiel","year":"2021","unstructured":"Amiel SA. The consequences of hypoglycaemia. Diabetologia. 2021;64:963\u201370.","journal-title":"Diabetologia"},{"key":"3942_CR31","doi-asserted-by":"crossref","unstructured":"Manoharan J, Albers MB, Rinke A, Adelmeyer J, G\u00f6rlach J, Bartsch DK. Multiple Endocrine Neoplasia Type 1: The Current Status of Disease Management. Dtsch Arztebl Int. 2024(Forthcoming).","DOI":"10.3238\/arztebl.m2024.0094"},{"key":"3942_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4143\/crt.2013.102","volume":"46","author":"HS Kim","year":"2014","unstructured":"Kim HS, Lee HS, Nam KH, Choi J, Kim WH. p27 Loss Is Associated with Poor Prognosis in Gastroenteropancreatic Neuroendocrine Tumors. Cancer Res Treat. 2014;46:383\u201392.","journal-title":"Cancer Res Treat"},{"key":"3942_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20605","volume":"29","author":"MC Lemos","year":"2008","unstructured":"Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat. 2008;29:22\u201332.","journal-title":"Hum Mutat"},{"key":"3942_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cancergen.2015.12.002","volume":"209","author":"P Concolino","year":"2016","unstructured":"Concolino P, Costella A, Capoluongo E. Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years. Cancer Genet. 2016;209:36\u201341.","journal-title":"Cancer Genet"},{"key":"3942_CR35","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1210\/jc.2018-01170","volume":"104","author":"P Romanet","year":"2019","unstructured":"Romanet P, Mohamed A, Giraud S, Odou MF, North MO, Pertuit M, et al. UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French Population. J Clin Endocrinol Metab. 2019;104:753\u201364.","journal-title":"J Clin Endocrinol Metab"},{"key":"3942_CR36","doi-asserted-by":"publisher","first-page":"K1","DOI":"10.1530\/EJE-22-0171","volume":"187","author":"L Coppin","year":"2022","unstructured":"Coppin L, Giraud S, Pasmant E, Lagarde A, North MO, Le-Collen L, et al. Multiple endocrine neoplasia type 1 caused by mosaic mutation: clinical follow-up and genetic counseling? Eur J Endocrinol. 2022;187:K1-k6.","journal-title":"Eur J Endocrinol"},{"key":"3942_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","volume":"123","author":"A Yokoyama","year":"2005","unstructured":"Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M, Cleary ML. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell. 2005;123:207\u201318.","journal-title":"Cell"},{"key":"3942_CR38","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.1038\/sj.onc.1205822","volume":"21","author":"A Gallo","year":"2002","unstructured":"Gallo A, Cuozzo C, Esposito I, Maggiolini M, Bonofiglio D, Vivacqua A, et al. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation. Oncogene. 2002;21:6434\u201345.","journal-title":"Oncogene"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03942-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03942-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03942-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T18:03:35Z","timestamp":1757268215000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03942-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3942"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03942-8","relation":{},"ISSN":["1477-7819"],"issn-type":[{"type":"electronic","value":"1477-7819"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the human research ethics committees of the Chinese PLA General Hospital(protocol code S2015-038\u201301). The patient has read and signed the informed consent form to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient's written informed consent to publish this case report. The family release information to collate medical records from multiple healthcare systems. For reasons of patient privacy, the corresponding author may be contacted if research participant publication approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"294"}}